Over time
China over time. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.
Innovative drug out-licensing deal count
China, 2024 to 2025
Every record
4 records · 1 region · 2024–2025. Each period links to its record: the value, its source evidence and original document.
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: MOFCOM and NHSA. Licence: CC BY 4.0.
Embed this chart
For automatic sizing and multiple charts, see the JavaScript embed guide.
Free to embed anywhere, including commercially. The attribution bar is part of the chart. The link under the frame is optional: keep it, remove it or mark it rel="nofollow".
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (MOFCOM and NHSA); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Total number of out-licensing transactions concluded for innovative pharmaceutical products.
- Measure
- One slice of Out-licensing deals ( form: count, segment: innovative ) . Total number of out-licensing agreements concluded for pharmaceutical assets. Region and period are columns on every record, not slices.
- Limitations
- Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.
Sources · 2 documents
| Document | Publisher | Published | Data points |
|---|---|---|---|
| 2025年我国批准创新药76个 对外授权超千亿美元 | MOFCOM | — | 2 |
| 创新高！去年我国批准创新药76个 对外授权破千亿美元 | NHSA | — | 2 |
Other slices of out-licensing deals
- Innovative drug out-licensing deal count (half year) 1 innovative
- Share of global biopharmaceutical licensing deals 1 biopharmaceutical
Frequently asked questions
What is the latest innovative drug out-licensing deal count?
China: 157 in 2025, +67.0% on 2024.
Where does this data come from?
From 2 documents published by MOFCOM and NHSA. Every figure on this page links to its record, which preserves the original source evidence.
How often is it updated?
Annual. The newest published period is 2025; the next release should cover 2026. A new figure appears here once the publisher releases it and it passes verification.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Innovative drug out-licensing deal count [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/innovative-drug-out-licensing-deal-count
"Innovative drug out-licensing deal count." StatOrigin, 2026, https://statorigin.org/indicators/innovative-drug-out-licensing-deal-count. Accessed 28 Oct. 2026.
StatOrigin. "Innovative drug out-licensing deal count." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/innovative-drug-out-licensing-deal-count.
@misc{statorigin_innovative_drug_out_licensing_deal_count_2026, title = {Innovative drug out-licensing deal count}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/innovative-drug-out-licensing-deal-count}, note = {Data set. Accessed 2026-10-28} }